Lithium does help reduce anger and impulsive aggression, and it’s one of the better-studied medications for this purpose. Originally used to treat bipolar disorder, lithium has shown consistent results in clinical trials targeting aggressive behavior, even in people without a bipolar diagnosis. Its effects on anger typically begin within one to three weeks of starting treatment.
What the Clinical Evidence Shows
The strongest evidence comes from controlled trials where lithium was tested specifically against aggression. In a double-blind study of hospitalized children and adolescents with conduct disorder (ages 10 to 17), 80% of those taking lithium were classified as treatment responders, compared to just 20% on placebo. Participants were more than nine times as likely to respond to lithium than to placebo, and their scores on a standardized aggression scale dropped significantly. A separate study of adults found that over 63% of participants experienced at least a 30% reduction in aggressive episodes after starting lithium.
Lithium has also been used off-label for intermittent explosive disorder, a condition defined by recurrent, disproportionate outbursts of anger. Mood stabilizers are a standard pharmacological approach for this condition, and lithium is among the most commonly used. In one documented case, a patient with explosive anger reported a complete cessation of violent outbursts after reaching therapeutic lithium levels.
How Lithium Reduces Aggression
Lithium works on anger through multiple pathways in the brain. It modulates the activity of both dopamine and serotonin, two chemical messengers that play central roles in mood regulation and impulse control. By rebalancing these systems, lithium helps dampen the hair-trigger reactivity that drives explosive anger.
There’s also a deeper mechanism at play. Lithium inhibits an enzyme called GSK-3, which promotes inflammation in the brain. This enzyme has been directly linked to aggressive behavior in animal studies, and it becomes more active under chronic stress. By blocking GSK-3, lithium reduces the brain inflammation that appears to fuel aggression, impulsivity, and mood instability. This anti-inflammatory effect may explain why lithium works for anger even in people who don’t have a classic mood disorder.
Lithium Outperforms Other Mood Stabilizers
Not all mood stabilizers are equally effective for anger and impulsivity. When researchers compared lithium head-to-head with valproate (another commonly prescribed mood stabilizer), lithium reduced impulsive behavior while valproate had no effect on impulsive decision-making. This finding held across multiple studies: lithium consistently decreased aggression in laboratory models, while neither valproate nor carbamazepine did.
The difference extends beyond aggression. Suicide risk, which is closely tied to impulsivity and emotional dysregulation, is 2.7 times higher in people taking valproate compared to lithium. A meta-analysis confirmed that lithium is more effective than anticonvulsants, antidepressants, or placebo at reducing suicide, self-harm, and overall mortality in people with mood disorders. For someone whose anger stems from poor impulse control, this distinction matters.
How Quickly It Works
Lithium is not an immediate fix. Most people need one to three weeks before they notice meaningful changes. In a study tracking weekly progress, about a third of participants showed significant improvement within the first week, and 63% responded by day 28. Early improvement during the first week turns out to be a reliable predictor of whether lithium will work for you over the longer term. If you see at least a modest reduction in symptoms by week one, the odds of a full response by the end of the first month are good.
Side Effects to Expect
Lithium’s main drawback is its narrow therapeutic window, meaning the difference between an effective dose and a toxic one is relatively small. Standard blood levels for maintenance treatment fall between 0.60 and 0.80 mmol/L, though doctors may adjust this range based on how well you respond and how well you tolerate the medication.
The most common side effects are manageable but persistent. Up to 70% of long-term users experience increased thirst and frequent urination. About one in four develops a hand tremor. Nausea affects 10 to 20% of people early on but usually fades over time, and diarrhea occurs in up to 10% during the first six months. Weight gain and cognitive dulling, like feeling mentally “foggy,” tend to be the side effects that bother people most and are the main reasons people stop taking the medication.
Mild toxicity shows up as weakness, worsening tremor, poor concentration, and diarrhea. If levels climb higher, vomiting, slurred speech, confusion, and severe tremor can develop. Regular blood tests are essential to stay within the safe range, and long-term use requires monitoring of kidney and thyroid function.
What About Low-Dose Lithium Supplements?
Lithium orotate, sold as an over-the-counter supplement, is sometimes marketed as a gentler alternative to prescription lithium carbonate. There’s a grain of science behind this: research from the late 1970s found that lithium orotate delivers roughly three times more lithium to the brain than an equivalent dose of lithium carbonate. In theory, this means lower doses could achieve the same effect.
In practice, the evidence is thin. Lithium orotate was largely abandoned in the 1970s over toxicity concerns at equivalent doses, and researchers have never properly tested whether lower doses of orotate can match the therapeutic benefits of carbonate. There is a notable gap in the data on lithium orotate’s effectiveness for behavioral symptoms. The clinical trials demonstrating lithium’s benefits for aggression all used prescription lithium carbonate under medical supervision, not supplement-grade orotate.